A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
Clinical trial NCT06771063 · RECRUITING
Trial details
- NCT number
- NCT06771063
- Sponsor
- Cisen Pharmaceutical CO., LTD.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-13
- Primary completion
- 2025-07-10
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.